Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19

…, LM Beskow, J Brown, SM Brown, É Gayat… - The Lancet …, 2022 - thelancet.com
Unique challenges arise when conducting trials to evaluate therapies already in common
clinical use, including difficulty enrolling patients owing to widespread open-label use of trial …

Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients

V Léopold, E Gayat, R Pirracchio, J Spinar… - Intensive care …, 2018 - Springer
Objective Catecholamines have been the mainstay of pharmacological treatment of
cardiogenic shock (CS). Recently, use of epinephrine has been associated with detrimental …

Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta‐regression in the past four decades

…, G Chassard, H Pegorer‐Sfes, E Gayat… - European Journal of …, 2021 - Wiley Online Library
Aims Acute heart failure (AHF) is frequent and life‐threatening disease. However, innovative
AHF therapies have remained limited, and care is based on experts' opinion. Temporal …

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised …

…, K Takagi, A Damasceno, H Saidu, E Gayat… - The Lancet, 2022 - thelancet.com
Background There is a paucity of evidence for dose and pace of up-titration of guideline-directed
medical therapies after admission to hospital for acute heart failure. Methods In this …

Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study

M Legrand, C Dupuis, C Simon, E Gayat, J Mateo… - Critical care, 2013 - Springer
Introduction The role of systemic hemodynamics in the pathogenesis of septic acute kidney
injury (AKI) has received little attention. The purpose of this study was to investigate the …

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute …

J Lassus, E Gayat, C Mueller, WF Peacock… - International journal of …, 2013 - Elsevier
Aim This study aims to evaluate the incremental value of plasma biomarkers to traditional
clinical variables for risk stratification of 30-day and one-year mortality in acutely …

Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods

A Mebazaa, J Parissis, R Porcher, E Gayat… - Intensive care …, 2011 - Springer
Purpose To date, treatment with intravenous (IV) agents such as vasodilators, diuretics, and
inotropes has shown marginal or mixed benefits in acute heart failure (AHF) trials. The aim …

Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox

R Shah, E Gayat, JL Januzzi, N Sato… - Journal of the American …, 2014 - jacc.org
Objectives : This study sought to define the relationship between body mass index (BMI) and
mortality in heart failure (HF) across the world and to identify specific groups in whom BMI …

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

…, W Frank Peacock, K Sliwa, E Gayat… - European heart …, 2010 - academic.oup.com
Aims The vast majority of acute heart failure (AHF) trials to date have targeted dyspnoea.
However, they enrolled patients relatively late and did not standardize their methods of …

Precipitating factors and 90‐day outcome of acute heart failure: a report from the intercontinental GREAT registry

M Arrigo, E Gayat, J Parenica, S Ishihara… - European journal of …, 2017 - Wiley Online Library
Aims Several clinical conditions may precipitate acute heart failure ( AHF ) and influence
clinical outcome. In this study we hypothesized that precipitating factors are independently …